Chitogenx Stock Number Of Employees
| CHNXF Stock | USD 0.01 0.00 0.00% |
ChitogenX fundamentals help investors to digest information that contributes to ChitogenX's financial success or failures. It also enables traders to predict the movement of ChitogenX OTC Stock. The fundamental analysis module provides a way to measure ChitogenX's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChitogenX otc stock.
ChitogenX |
ChitogenX OTC Stock Number Of Employees Analysis
ChitogenX's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current ChitogenX Number Of Employees | 6 |
Most of ChitogenX's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChitogenX is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, ChitogenX is currently employing 6.0 people. This is 99.95% lower than that of the Healthcare sector and 98.88% lower than that of the Biotechnology industry. The number of employees for all United States stocks is 99.97% higher than that of the company.
ChitogenX Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChitogenX's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of ChitogenX could also be used in its relative valuation, which is a method of valuing ChitogenX by comparing valuation metrics of similar companies.ChitogenX is currently under evaluation in number of employees category among its peers.
ChitogenX Fundamentals
| Return On Asset | -2.92 | |||
| Current Valuation | 12.49 M | |||
| Shares Outstanding | 51.04 M | |||
| Shares Owned By Insiders | 17.44 % | |||
| EBITDA | (3.72 M) | |||
| Net Income | (4.92 M) | |||
| Cash And Equivalents | 2.19 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 4.78 M | |||
| Current Ratio | 1.26 X | |||
| Book Value Per Share | (0.15) X | |||
| Cash Flow From Operations | (3.22 M) | |||
| Beta | 0.43 | |||
| Market Capitalization | 9.86 M | |||
| Total Asset | 1.12 M | |||
| Z Score | -8.7 | |||
| Net Asset | 1.12 M |
About ChitogenX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChitogenX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChitogenX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChitogenX based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ChitogenX OTC Stock
ChitogenX financial ratios help investors to determine whether ChitogenX OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChitogenX with respect to the benefits of owning ChitogenX security.